Denali Therapeutics Overview
Denali Therapeutics Discounted Cash Flow
DCF Analysis for DNLI.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.96
Current Fair Value
$0.96
↓ 95.7% Downside
Overvalued by 95.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison